SCHEMBL13367607

SCHEMBL13367607

Cc1ccc2cc(N(c3cccc4ccccc34)c3cccc4ccccc34)ccc2c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 6/20 0.50
TDP1 Q9NUW8 2/20 0.50
CYP1A2 P05177 6/20 0.49
SIGMAR1 Q99720 5/20 0.41
MAOA P21397 2/20 0.41
HTT P42858 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
ALDH1A1 P00352 2/20 0.38
HPGD P15428 1/20 0.38
HSD17B10 Q99714 1/20 0.38
MAOB P27338 1/20 0.38
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
NPC1 O15118 1/20 0.36
GAA P10253 1/20 0.36
MAPT P10636 1/20 0.36
RAB9A P51151 1/20 0.36
NOX1 Q9Y5S8 1/20 0.36
MCL1 Q07820 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14242300 0.95 CYP2A6 (0.53) CYP2A6TDP1CYP1A2SIGMAR1MAOA
SCHEMBL13367566 0.92 CYP2A6 (0.46) CYP2A6TDP1CYP1A2SIGMAR1MAOA
SCHEMBL5504032 0.92 CYP2A6 (0.43) CYP2A6TDP1CYP1A2SIGMAR1MAOA
SCHEMBL13829463 0.91 CYP2A6 (0.49) CYP2A6TDP1CYP1A2SIGMAR1MAOA
SCHEMBL18134987 0.91 HTT (0.44) CYP2A6TDP1CYP1A2SIGMAR1MAOA
SCHEMBL17702092 0.90 CYP2A6 (0.44) CYP2A6TDP1CYP1A2SIGMAR1MAOA
SCHEMBL29527479 0.90 SIGMAR1 (0.44) CYP2A6TDP1CYP1A2SIGMAR1ALDH1A1
SCHEMBL78401 0.90 SIGMAR1 (0.44) CYP2A6TDP1CYP1A2SIGMAR1ALDH1A1
SCHEMBL5051402 0.89 L3MBTL1 (0.43) CYP2A6TDP1CYP1A2SIGMAR1MAOA
SCHEMBL18134984 0.89 HTT (0.46) CYP2A6TDP1CYP1A2SIGMAR1MAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100108997-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-05-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100108997-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same OR10J3, OCIAD1, OCIAD2 CYP2A6 2286/4885TDP1 3318/4885CYP1A2 1021/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.